you are here: HomeNewsIndia

Coronavirus update: India's COVID-19 caseload rises to 1,05,95,660; recovery rate at 96.7%

The total number of people who have recuperated from the disease surged to 1,02,45,741, pushing the national COVID-19 recovery rate to 96.70 percent.

January 20, 2021 / 10:31 AM IST
Relatives mourn the death of a man due to the coronavirus disease (COVID-19), at a crematorium in New Delhi. (Image: Reuters)

Relatives mourn the death of a man due to the coronavirus disease (COVID-19), at a crematorium in New Delhi. (Image: Reuters)

With 13,823 infections reported in a day, India's COVID-19 caseload rose to 1,05,95,660, while the recoveries surged to 1,02,45,741, the Union health ministry said on Wednesday. The death toll due to the disease increased to 1,52,718 in the country as 162 new fatalities were recorded, the ministry data updated at 8 am showed.

The total number of people who have recuperated from the disease surged to 1,02,45,741, pushing the national COVID-19 recovery rate to 96.70 percent.

The COVID-19 case fatality rate stands at 1.44 percent, it said.

The active caseload remained below 3 lakh. There are1,97,201 active coronavirus infections in the country, which comprises 1.86 percent of the total caseload,the data stated.

India's COVID-19 tally had crossed the 20 lakh-mark on August 7,30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28,70 lakh on October 11, 80 lakh on October 29,90 lakh on November 20 and surpassed the one crore-mark on December 19.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

According to the Indian Council of Medical Research (ICMR),18,85,66,947 samples have been tested till January 19, with7,64,120 samples being tested on Tuesday.

(With PTI inputs)
Moneycontrol News
first published: Jan 20, 2021 10:15 am

stay updated

Get Daily News on your Browser
Sections